Literature DB >> 2967348

Alexithymia and somatization. A Rorschach study of four psychosomatic groups.

M W Acklin1, G Alexander.   

Abstract

The construct of alexithymia has been postulated as a predisposing factor in psychosomatic illness. The alexithymia construct has achieved wide currency in psychosomatic research and theorizing despite its doubtful psychometric foundations. Also, the question of between-group variability in alexithymia has not been addressed. In this study we proposed and tested a Rorschach measure of alexithymia on four groups of psychosomatic patients (back pain, gastrointestinal, dermatology, migraine headache). It was hypothesized that psychosomatic groups would be more alexithymic than nonpatients. To examine the question of between-group variability in alexithymia, it was hypothesized that back pain patients would be more alexithymic than other psychosomatic groups. Both hypotheses were supported. Additionally, exploratory comparisons between psychosomatic groups revealed a number of differences between the groups in basic personality processes. The findings show promise for the use of the Rorschach test as an alexithymia measure. Based on the current study, heterogeneous grouping of psychosomatic patients in research designs and treatment programs appear to be a highly questionable procedure.

Entities:  

Mesh:

Year:  1988        PMID: 2967348

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Alexithymia and 7.5-year incidence of compensated low back pain in 1207 urban public transit operators.

Authors:  Wolf E Mehling; Niklas Krause
Journal:  J Psychosom Res       Date:  2007-06       Impact factor: 3.006

Review 2.  The assessment of alexithymia in medical settings: implications for understanding and treating health problems.

Authors:  Mark A Lumley; Lynn C Neely; Amanda J Burger
Journal:  J Pers Assess       Date:  2007-12

3.  Eating disordered patients: personality, alexithymia, and implications for primary care.

Authors:  D L Beales; R Dolton
Journal:  Br J Gen Pract       Date:  2000-01       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.